M&A Deal Summary

Revvity Acquires BioLegend

On July 26, 2021, Revvity acquired life science company BioLegend for 5.3B USD

Acquisition Highlights
  • This is Revvity’s 8th transaction in the Life Science sector.
  • This is Revvity’s largest (disclosed) transaction.
  • This is Revvity’s 19th transaction in the United States.
  • This is Revvity’s 3rd transaction in California.

M&A Deal Summary
Date 2021-07-26
Target BioLegend
Sector Life Science
Buyer(s) Revvity
Deal Type Add-on Acquisition
Deal Value 5.3B USD
Advisor(s) J.P. Morgan Securities (Financial)
Pillsbury Winthrop Shaw Pittman (Legal)

Target

BioLegend

San Diego, California, United States
BioLegend is a provider of life science antibodies and reagents for biomedical research. BioLegend is based in San Diego, California.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Revvity

Waltham, Massachusetts, United States
Category Company
Founded 1937
Sector Medical Products
Employees11,000
Revenue 2.8B USD (2023)
DESCRIPTION

Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Revvity was formerly known as PerkinElmer. The Company was formed in 1937 and is based in Waltham, Massachusetts.

DEAL STATS #
Overall 36 of 36
Sector (Life Science) 8 of 8
Type (Add-on Acquisition) 34 of 34
State (California) 3 of 3
Country (United States) 19 of 19
Year (2021) 5 of 5
Size (of disclosed) 1 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-06-22 SIRION Biotech

Martinsried, Germany

SIRION Biotech is a provider of viral vector-based technologies that drive improved delivery performance for cell and gene therapies. SIRION Biotech was founded in 2005 and is based in Martinsried, Germany.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-08-01 PerkinElmer

Shelton, Connecticut, United States

PerkinElmer is a global analytics services and solutions provider for the biopharma, food, environmental, safety and applied end markets. The Company offers a comprehensive portfolio of atomic spectroscopy, molecular spectroscopy, and chromatography instruments, consumables, and reagents, as well as laboratory services through the leading OneSource platform. PerkinElmer is based in Shelton, Connecticut.

Sell $2.5B
Mergr

Product

Company

Legal